Estrella Immunopharma Warrant
ESLAW
11 hedge funds and large institutions have $306K invested in Estrella Immunopharma Warrant in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
4% more capital invested
Capital invested by funds: $296K → $306K (+$10.4K)
0.12% less ownership
Funds ownership: 2.22% → 2.1% (-0.12%)
15% less funds holding
Funds holding: 13 → 11 (-2)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
+$4.75K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$4.75K |
| 2 |
RCM
Robinson Capital Management
Grosse Pointe Farms,
Michigan
|
-$759 |
| 3 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$271 |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$89 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $228K | – | – | – |
|
|
HCM
2
Highbridge Capital Management
New York
| $32.4K | – | – | – |
|
|
ASM
3
ATW SPAC Management
New York
| $12.7K | – | – | – |
|
|
4
Walleye Trading
New York
| $8.17K | +$4.75K | +55,782 | +150% |
|
5
D.E. Shaw & Co
New York
| $7.69K | – | – | – |
|
|
YCM
6
Yakira Capital Management
Westport,
Connecticut
| $4.27K | – | – | – |
|
|
SIA
7
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $4K | – | – | – |
|
|
WA
8
Whitebox Advisors
Minneapolis,
Minnesota
| $3.89K | -$271 | -3,183 | -7% |
|
|
CS
9
Clear Street
New York
| $2.63K | – | – | – |
|
|
LCM
10
Landscape Capital Management
Englewood,
New Jersey
| $1.26K | – | – | – |
|
|
11
Walleye Capital
New York
| $908 | -$4.75K | -55,782 | -84% |
|
|
WAM
12
Wolverine Asset Management
Chicago,
Illinois
| $299 | -$89 | -1,047 | -24% |
|
|
CAC
13
Cowen and Company
New York
| – | -$2.29K | -35,599 | Closed |
|
|
RCM
14
Robinson Capital Management
Grosse Pointe Farms,
Michigan
| – | -$759 | -11,805 | Closed |
|
ESLAW Hedge Fund Activity: Q4 2024 in Review
11 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q4 2024, worth a combined $306K — up 3.5% from $296K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ESLAW and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Walleye Trading, adding an estimated $4.75K. The largest seller was Walleye Capital, cutting an estimated $4.75K.
- 11 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q4 2024, down from 13 in Q3 2024.
- Funds reported $306K of Estrella Immunopharma Warrant stock for Q4 2024, up 3.5% quarter-over-quarter.
- 0 funds opened new Estrella Immunopharma Warrant positions in Q4 2024 and 2 closed out, a net change of -2 holders.
- The largest Estrella Immunopharma Warrant buyer in Q4 2024 was Walleye Trading, an estimated $4.75K added.
- The largest Estrella Immunopharma Warrant seller in Q4 2024 was Walleye Capital, an estimated $4.75K sold.
Based on aggregated 13F filings for Q4 2024.